Symbol: TSX-V: BABY, OTC: BABYF
VANCOUVER, Oct. 31, 2019 /CNW/ - Else Nutrition Holdings Inc. ("Else Nutrition" or the "Company"), (TSX-V: BABY, OTC: BABYF), a company focused on developing and marketing a real alternative to dairy-based baby nutrition, is pleased to make the following announcement regarding its commitment to developing the next generation of clean label baby nutrition products.
- Company's infant and baby toddler formulas are comprised of just 3 main ingredients made using clean, chemical-free process, by using 2 whole plants in their natural form.
Unlike many baby formulas, Else Nutrition's all-natural, 100% plant-based formula is being produced using a clean production process, transforming two whole plants, without chemically-breaking them up into derivatives, nor using chemical extraction of oils. Namely, the formula is devoid of highly-processed ingredients, purified oil blends, chemical protein isolates or hydrolysates. Additionally, the production process occurs without the addition of free amino acids, and no use of corn syrup solids. The formula contains only 3 main ingredients (superfoods almonds and buckwheat, as well as tapioca) which comprise 97% of the formula.
"Our science-backed process is significantly different in that we utilize the whole almond and buckwheat plant, and through all-natural processes create an infant formula that imitates breast milk nutritional composition values, and meets the strict WHO guidelines," stated Hamutal Yitzhak, Else Nutrition Co-Founder and CEO.
She added, "We've closely listened to parents and caregivers, and understand their deep-rooted need for nutritious and responsible, clean ingredient panel solutions for infants. We are committed to developing clean label baby and toddler nutrition, made with the cleanest process. We therefore take great care to use as few ingredients as possible, and ones that are nutritious and wholesome for children."
Else Nutrition's sustainable 100% plant-based, all-natural and organic baby formula is free of hormones, antibiotics, hexane, gluten, GMO, and solvents. The company will be launching its toddler formula & nutritional drink in North American market in Q2-2020, with plans to launch the infant formula in the coming years.
About Else Nutrition Holdings Inc.
The Company is a food and nutrition company focused on research, development, manufacturing, marketing, sale and/or license of innovative plant-based food and nutrition products to the infant, toddler, children and adult markets. Its revolutionary 100% plant-based non-soy alternative to dairy-based baby formula received the "Best Health and Diet Solutions" award in the Global Food Innovation Summit in Milan in May 2017.
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that, to the extent they are not recitations of historical fact, constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will", "expect", "plan", or "may" or similar expressions. Forward-looking statements in this press release include, but are not limited to, statements with respect to required regulatory approval and the manner of services provided by individuals engaged by the Company.
Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management's perception of historical trends, current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. Management's estimates, beliefs and assumptions are inherently subject to business, economic, competitive so no assurance can be given that the foregoing will prove to be correct.
Numerous risks and uncertainties could cause the Company's actual results or events to differ materially from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements, including, but not limited to: consumer demand for the Company's products, whether the current and future products achieve commercialization, obtaining necessary regulatory approvals, competitive developments, uncertainty regarding material changes in laws and regulations, and other risks set out in the Company's continuous disclosure record, including the Filing Statement dated May 14, 2019 under the heading "Risk Factors", that may be accessed through the SEDAR website (www.sedar.com).
Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
SOURCE Else Nutrition Holdings Inc.
For further information: visit elsenutrition.com or please contact: Hamutal Yitzhak, CEO, Co-Founder & Director of Else Nutrition Holdings Inc., E:[email protected], T: +972(0)52-447-9931